Biocompatible peptide-based hydrogels as nanocarriers for a new antitumoral drug
In this work, several new hydrogelators were developed, containing a Naproxen or a Naphthalene group. The ability of these hydrogels to act as nanocarriers for an antitumoral drug was investigated.
Autor principal: | |
---|---|
Outros Autores: | , , , , , , , |
Formato: | conferenceObject |
Idioma: | eng |
Publicado em: |
2014
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/1822/30743 |
País: | Portugal |
Oai: | oai:repositorium.sdum.uminho.pt:1822/30743 |